**Author details**

Leisheng Zhang1,2,3,4,5,6\*, Zhihai Han4 , Zhongchao Han4,5,6 and Hui Cai1

1 Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province and NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China

2 CAS Key Laboratory of Radiation Technology and Biophysics in Institute of Biology and Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, China

3 Center for Cellular Therapies, The First Affiliated Hospital of Shandong First Medical University, Ji-nan, China

4 Jiangxi Research Center of Stem Cell Engineering, Jiangxi Health-Biotech Stem Cell Technology Co., Ltd., Shangrao, China

5 Institute of Health-Biotech, Health-Biotech (Tianjin) Stem Cell Research Institute Co., Ltd, Tianjin, China

6 Stem Cell Bank of Guizhou Province, Guizhou Health-Biotech Biotechnology Co., Ltd., Guiyang, China

\*Address all correspondence to: leisheng\_zhang@163.com

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Mesenchymal Stem Cell-based Cytotherapy for Osteoarthritis Management: State of the Art DOI: http://dx.doi.org/10.5772/intechopen.108258*
